Serial Number 88167580
Registration 6634105
700

Registration Progress

Application Filed
Oct 24, 2018
Under Examination
Jun 4, 2019
Approved for Publication
Apr 9, 2019
Published for Opposition
Apr 9, 2019
Registered
Feb 1, 2022

Trademark Image

Basic Information

Serial Number
88167580
Registration Number
6634105
Filing Date
October 24, 2018
Registration Date
February 1, 2022
Published for Opposition
April 9, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 1, 2022
Registration
Registered
Classes
005 042

Rights Holder

ExcellThera Inc.

03
Address
2950 Chemin de Polytechnique
Montreal, Quebec H3T1J4
CA

Ownership History

ExcellThera Inc.

Original Applicant
03
Montreal, Quebec CA

ExcellThera Inc.

Owner at Publication
03
Montreal, Quebec CA

ExcellThera Inc.

Original Registrant
03
Montreal, Quebec CA

Legal Representation

Attorney
Ernest V. Linek

USPTO Deadlines

Next Deadline
740 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220201)
Due Date
February 01, 2028
Grace Period Ends
August 01, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Feb 1, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 29, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 28, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 28, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 3, 2021 IUAF S USE AMENDMENT FILED Loading...
Dec 28, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 3, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 1, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 1, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 23, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 23, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 23, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 16, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 14, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 14, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
May 14, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 5, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 3, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 3, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 3, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 4, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 9, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 9, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 4, 2019 ALIE A ASSIGNED TO LIE Loading...
Feb 12, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 12, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 12, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 12, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 31, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 7, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 6, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 27, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations in the nature of stem cells solutions to enable stem cell expansion for therapeutic purposes, used in hematopoietic stem cell transplantation (HSCT) for patients with blood cancers; Bioengineering pharmaceutical solutions containing small molecules for use in expanding cells for therapeutic use to patients with blood cancers and other diseases
First Use Anywhere: Jun 25, 2021
First Use in Commerce: Jun 25, 2021
Class 042
Medical and scientific research in the field of stem cells; medical laboratory research; medical and scientific research, namely, conducting pre-clinical and clinical trials for others
First Use Anywhere: Jun 25, 2021
First Use in Commerce: Jun 25, 2021

Additional Information

Design Mark
The mark consists of six juxtaposed triangles, several with truncated edges, one of each in purple, red, pink, yellow, green and blue.
Color Claim
The color(s) purple, red, pink, yellow, blue and green is/are claimed as a feature of the mark.

Classification

International Classes
005 042